Exploring the relationship between socioeconomic status and erectile dysfunction: an analysis of the National Health and Nutrition Examination Survey EJ Macdonald, JM Gaines, JI Kim, DA Paduch International Journal of Impotence Research 35 (5), 478-483, 2023 | 14 | 2023 |
Sequencing of PD-1/L1 inhibitors and carboplatin based chemotherapy for cisplatin ineligible metastatic urothelial carcinoma XX Wei, L Werner, MY Teo, JE Rosenberg, VS Koshkin, P Grivas, ... The Journal of urology 205 (2), 414-419, 2021 | 5 | 2021 |
Prospective randomized trial of antibiotic prophylaxis duration for percutaneous nephrolithotomy in low-risk patients L Griffiths, T Aro, P Samson, S Derisavifard, J Gaines, D Alaiev, G Mullen, ... Journal of endourology 37 (10), 1075-1080, 2023 | 3 | 2023 |
Race and ethnicity have a significant effect on the disclosure of erectile function: An analysis of NHANES response patterns JM Gaines, EJ Macdonald, AJ Smith, MA Diefenbach, DA Paduch Urology 167, 138-143, 2022 | 3 | 2022 |
Analysis of twitter engagement in a progressively more competitive urology match: A mixed methods study EJ Macdonald, JM Gaines, E Taubenfeld, K Labagnara, A Huang, ... Urology 167, 30-35, 2022 | 3 | 2022 |
First-line PD-1/PD-L1 inhibitor followed by carboplatin (carbo)-based chemotherapy (chemo) or the reverse sequence in cisplatin-ineligible metastatic urothelial cancer (mUC … XX Wei, K Lundgren, MY Teo, JE Rosenberg, VS Koshkin, P Grivas, ... Journal of Clinical Oncology 36 (15_suppl), e16517-e16517, 2018 | 3 | 2018 |
Treatment sequencing of anti-PD-1/PD-L1 and carboplatin (carbo)-based chemotherapy (chemo) in cisplatin-ineligible patients (pts) with metastatic urothelial cancer (mUC). XX Wei, L Werner, MY Teo, JE Rosenberg, VS Koshkin, P Grivas, ... Journal of Clinical Oncology 37 (15_suppl), 4541-4541, 2019 | 1 | 2019 |
MP13-02 COMPARING MFI-5, ASA CLASS, AND MCCI AS PREDICTORS OF POSTOPERATIVE OUTCOMES FOLLOWING ENDOSCOPIC TREATMENT OF BPH J James, G Jun, J Gaines, Z Okeke, G Mullen, A Rai Journal of Urology 209 (Supplement 4), e173, 2023 | | 2023 |
MP09-16 INFORMING AN APPROACH TO THE SUBCAPSULAR RENAL HEMATOMA (SRH): A TEN-YEAR REVIEW OF THE NATURAL HISTORY AND PROGRESSION OF SRH E Lynch, J Gaines, J James, T Aro, D Hoenig, Z Okeke, A Smith, A Rai Journal of Urology 209 (Supplement 4), e111, 2023 | | 2023 |
HF01-11 TRIALS OF VOIDING IN SPACE: HOW URINE SHAPED THE DEVELOPMENT OF SPACESUITS A Huang, J Gaines, J Kim Journal of Urology 209 (Supplement 4), e259, 2023 | | 2023 |
HF01-03 SEXUALITY AND SILVERWARE: THE STORY OF MALE CONTINENCE IN THE ONEIDA COMMUNITY E Macdonald, J Gaines, L Sebel, K Watts Journal of Urology 209 (Supplement 4), e256, 2023 | | 2023 |
Bilateral nephrolithiasis and upper tract transitional cell carcinoma in horseshoe kidney JM Gaines, EJ Macdonald, A Rai, D Hoenig, A Smith, Z Okeke, T Aro Current Urology, 10.1097, 2022 | | 2022 |
HF02-05 FROM STERILE TO CLEAN: DRAMATIC CHANGES IN CATHETERIZATION DURING THE 1970s A Huang, J Gaines, A Winer Journal of Urology 207 (Supplement 5), e207, 2022 | | 2022 |
V13-11 SINGLE PORT ROBOT-ASSISTED LAPAROSCOPIC ADRENALECTOMY VIA MINI PFANNENSTIEL INCISION J James, A Rai, J Gaines, E Macdonald, M Vira Journal of Urology 207 (Supplement 5), e1034, 2022 | | 2022 |
Ethical Considerations for the Workup of the Microhematuria Patient. Letter. JM Gaines, EJ Macdonald, SJ Hall Journal of Urology 207 (5), 1161-1162, 2022 | | 2022 |
MP53-12 HOW DO PSA-BASED MARKERS PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER (CSPCA) ON PROSTATE BIOPSY INDEPENDENT OF PROSTATE SIZE M Kuster, M Ou, J Gaines, E Macdonald, S Hall Journal of Urology 207 (Supplement 5), e899, 2022 | | 2022 |
PD14-02 CRITICAL EVALUATION OF THE 2020 MICROHEMATURIA GUIDELINES: ARE WE STILL WORKING UP TOO MANY PATIENTS? E Macdonald, J Gaines, M Kuster, M Ou, E Taubenfeld, A Diamond, ... Journal of Urology 207 (Supplement 5), e256, 2022 | | 2022 |
PD08-08 IMPROVEMENT IN PAIN CATASTROPHIZING RELATED TO IMPROVED OUTCOMES IN PATIENTS WITH CHRONIC PELVIC PAIN (CPP) J Gaines, D Alaiev, L Nyman, S Pandya, D Wang, K Kunkle, ... The Journal of Urology 207 (Supplement 5), e108, 2022 | | 2022 |
HF01-02 MAKING THE PRIVATES PUBLIC: IMPOTENCE TRIALS IN PREREVOLUTIONARY FRANCE J Gaines, R Moldwin Journal of Urology 207 (Supplement 5), e211, 2022 | | 2022 |
MP58-04 PSA DENSITY DIRECTLY CORRELATES WITH PI-RADS LESION SCORE ON PROSTATE MRI C Martin, J Gaines, E Macdonald, M Kuster, S Hall The Journal of Urology 207 (Supplement 5), e992, 2022 | | 2022 |